- Ischemic stroke and low vitamin D – 3X higher risk of poor outcome, 6 X higher risk of a second stroke, Oct 2017
- Death within 2 years of surviving an ischemic stroke 10X less likely if high vitamin D – July 2017
- Much higher death rate 10 years after TIA – Nov 2011 – vitamin D might help
- Twice as many fatal strokes among whites who were low on vitamin D – Jan 2012
- Stroke rate increased 85 percent in young women in large cities in the Western US in a decade – June 2017
- Ischaemic stroke – Vitamin D doubled survival (Injection and 60,000 IU per month) – RCT Aug 2016
- Stroke outcome 6.9 X worse if black and overweight (all three related via low vitamin D) – March 2018
- Strokes 3 X worse if low vitamin D – Jan 2018
- Following strokes, brain scans (MRI) 3X worse in those having low vitamin D – July 2018
- ICU cost reduced by at least 27,000 dollars if get high dose vitamin D in first week - April 2017
- ICU survival increased with vitamin D single loading dose - JAMA Sept 2014
- Vitamin D loading doses reduce ICU mortality by 30 percent – meta-analysis April 2017
Quickly restore Vitamin D Levels
- Better outcome following Ischemic stroke if injected with 600,000 IU of vitamin D – RCT Feb 2017 Oral or sublingual loading doses may also improve outcome
- Overview Loading of vitamin D
- Injection category listing has
50 items along with related searches
Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients Dec 2017
J Neuroimmunol. 2017 Dec 15;313:41-45. doi: 10.1016/j.jneuroim.2017.10.002. Epub 2017 Oct 5.
Low Vitamin D (Q1) predicts far more likely to die
Nie Z1, Ji XC2, Wang J3, Zhang HX4.
- 1 Department of Radiology,The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China. Electronic address: nieyisheng at 163.com.
- 2 EEG Room,The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
- 3 Department of Radiology,The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
- 4 Department of Spinal Surgery,Henan, Luoyang Bone-Setting Hospital, Luoyang, China.
The aim of this study is to determine 25-hydroxyvitamin D [25(OH) D] levels in serum, and investigate their associations with cardiovascular disease (CVD) or all-cause mortality in a 1-year follow-up study in patients with first-ever ischemic stroke.
From November 2013 to October 2015, 387 consecutive patients with ischemic stroke admitted to our hospital were identified. Serum 25(OH) D levels were measured at admission. Infarct volume was measured using diffusion-weighted imaging (DWI). The primary end point was CVD mortality among 1year. The secondary end point was all-cause mortality.
In this study, 387 patients were included. A statistically significant negative correlation between serum 25(OH) D level and infarct volume was found (r=-0.442; P<0.001). There were 74 patients (19.1%, 95%CI: 15.2%-23.0%) died, including 36 CVD mortality (9.3%, 95CI%: 6.4%-12.2%). The mortality distribution across the 25(OH) D quartiles ranged between 39.2% (first quartile) to 5.2% (fourth quartile) for all-cause mortality and between 18.6% (first quartile) to 2.1% (fourth quartile) for CVD mortality. In a multivariate model using the first quartiles of 25(OH) D vs. quartiles 2 through 4 together with the clinical variables, the marker displayed prognostic information CVD mortality: OR for first quartile, 3.06 [95% CI, 2.16-4.95]; all-cause mortality: OR for first quartile, 2.76 [95% CI, 2.01-4.32].
The data show serum levels of 25(OH) D at admission is useful prognostic marker of CVD and all-cause mortality in Chinese patients with ischemic stroke.
PMID: 29153607 DOI: 10.1016/j.jneuroim.2017.10.002
Vitamin D deficiency in relation to the poor functional outcomes in nondiabetic patients with ischemic stroke.
Biosci Rep. 2018 Feb 5. pii: BSR20171509. doi: 10.1042/BSR20171509.
Wei ZN1, Kuang JG2.
Objective To assess the hypothesis that vitamin D, reflected by 25-hydroxyvitamin D [25(OH)D] would be associated with higher risk of poor functional outcomes among nondiabetic stroke patients.
Methods This study was conducted in Nanchang, China. Serum concentration of 25(OH) D and NIH stroke scale (NIHSS) were measured at the time of admission. Functional outcome was measured by modified Rankin scale (mRS) at 1 year after admission. Multivariate analyses were performed using logistic regression models. The cut point of 25(OH) D level for vitamin D deficiency was 20ng/ml.
Results In this study, 266 nondiabetic subjects with stroke were included. One hundred and forty-nine out of the 266 patients were defined as vitamin D deficiency (56%). The poor outcome distribution across the 25(OH) D quartiles ranged between 64% (first quartile) to 13% (fourth quartile). In those 149 patients with vitamin D deficiency, 75 patients were defined as poor functional outcomes, giving a prevalence rate of 50% (95% confidence intervalCI: 42%-58%). In multivariate analysis models, for vitamin D deficiency, the adjusted risk of poor functional outcomes and mortality increased by 220% (odds ratios [OR]: 3.2; 95% CI, 1.7-4.2, P<0.001) and 290% (OR: 3.9; 95% CI, 2.1-5.8, P<0.001), respectively.
Conclusions Vitamin D deficiency is associated with an increased risk of poor functional outcome events in Chinese nondiabetic stroke individuals.
PMID: 29437901 DOI: 10.1042/BSR20171509
1464 visitors, last modified 12 Dec, 2018, URL: